NIIMBL Announces Up To $4M Available for Technology and Workforce and $1.7M for Global Health Fund Projects
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce Project Call 8.1 for Technology, Workforce Development, and Global Health Fund projects.
NIIMBL announces 2 RFIs focused on data connectivity and federated learning for biopharmaceutical manufacturing
NIIMBL is pleased to announce two Requests for Information (RFI) related to universal connectivity and federated learning as part of the Institute’s Big Data Program.
NIIMBL and Open Applications Group (OAGi) partner to develop open-source biopharmaceutical manufacturing ontologies
NIIMBL has contributed biopharmaceutical manufacturing ontologies to The Open Applications Group (OAGi) for further development as an open-source project.
NIIMBL collaborates on review of vaccine process technology developments
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has published “Vaccine process technology—a decade of progress” in Biotechnology and Bioengineering. The paper serves as an update to a 2012 review titled “Vaccine process technology” authored by NIIMBL Executive Director Barry Buckland and explores transformations in vaccine development over the past decade.
NIIMBL announces 63 students for the 2024 NIIMBL eXperience
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce 63 students from 41 academic institutions have been selected to take part in the 2024 NIIMBL eXperience
NIIMBL Announces $10M for 8 New Biopharmaceutical Manufacturing Projects
NEWARK, Del., April 9, 2024 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $10M in planned project activities through the Institute’s Project Call 7.1 for eight new technology and workforce development projects that will help address key opportunities for innovation in biopharmaceutical manufacturing.